Inactive/Delisted stock
Protagenic Therapeutics Stock (NASDAQ:PTIX)
Previous Close
$3.48
52W Range
$2.35 - $15.82
50D Avg
$3.87
200D Avg
$6.40
Market Cap
$3.14M
Avg Vol (3M)
$2.04M
Beta
0.38
Div Yield
-
PTIX Company Profile
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.